BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38241373)

  • 21. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
    Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise facilitates early recognition of cardiac and vascular remodeling in chronic thromboembolic pulmonary hypertension in swine.
    Stam K; van Duin RWB; Uitterdijk A; Cai Z; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H627-H642. PubMed ID: 29167118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxia.
    Haslip M; Dostanic I; Huang Y; Zhang Y; Russell KS; Jurczak MJ; Mannam P; Giordano F; Erzurum SC; Lee PJ
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1166-78. PubMed ID: 25814675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factor-1 α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension.
    Kojima H; Tokunou T; Takahara Y; Sunagawa K; Hirooka Y; Ichiki T; Tsutsui H
    Physiol Rep; 2019 Apr; 7(7):e14025. PubMed ID: 30927327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling.
    Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Skinner JT; Poloczek A; El-Haddad H; Cheadle C; Johns RA
    Respir Res; 2013 Jan; 14(1):1. PubMed ID: 23289668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
    Boehm M; Arnold N; Braithwaite A; Pickworth J; Lu C; Novoyatleva T; Kiely DG; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Lawrie A; Schermuly RT; Kojonazarov B
    BMC Pulm Med; 2018 Mar; 18(1):41. PubMed ID: 29499691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hypoxia-induced alterations of the right ventricular myocardium are not aggravated by alimentary obesity in the mouse.
    Mühlfeld C; Bienas LM; Bornemann M; Schipke J
    Microvasc Res; 2024 Jan; 151():104618. PubMed ID: 37884172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
    Bonnet S; Michelakis ED; Porter CJ; Andrade-Navarro MA; Thébaud B; Bonnet S; Haromy A; Harry G; Moudgil R; McMurtry MS; Weir EK; Archer SL
    Circulation; 2006 Jun; 113(22):2630-41. PubMed ID: 16735674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of collagen synthesis in ventricular and vascular adaptation to hypoxic pulmonary hypertension.
    Schreier D; Hacker T; Song G; Chesler N
    J Biomech Eng; 2013 Feb; 135(2):021018. PubMed ID: 23445063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
    Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension.
    Jaijee S; Quinlan M; Tokarczuk P; Clemence M; Howard LSGE; Gibbs JSR; O'Regan DP
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H950-H957. PubMed ID: 29775415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension.
    Li X; He Y; Xu Y; Huang X; Liu J; Xie M; Liu X
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(4):L299-310. PubMed ID: 26702149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.
    Beloiartsev A; da Glória Rodrigues-Machado M; Zhou GL; Tan TC; Zazzeron L; Tainsh RE; Leyton P; Jones RC; Scherrer-Crosbie M; Zapol WM
    Am J Respir Cell Mol Biol; 2015 May; 52(5):563-70. PubMed ID: 25233285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.